Rituximab plus gemcitabine and oxaliplatin in patients with refractory/relapsed diffuse large B-cell lymphoma who are not candidates for high-dose therapy. A phase II Lymphoma Stud...

Por Mounier, Nicolas, El Gnaoui, Taoufik, Tilly, Hervé, Canioni, Danièle, Sebban, Catherine, Casasnovas, René-Olivier, Delarue, Richard, Sonet, Anne, Beaussart, Pauline, Petrella, Tony, Castaigne, Sylvie, Bologna, Serge, Salles, Gilles, Rahmouni, Alain, Gaulard, Philippe, Haioun, Corinne
Publicado em 2013